Researchers at Tel Aviv University, led by Prof. Illana Gozes, examined the effects of different mutations in the ADNP protein, which is essential for normal brain development and aging, on the brain ...
Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an ...
Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...
The U.S. Department of Energy granted Dr. Jean-Michel Ané and his colleagues $5.5 million to study systems to cut synthetic ...
A gene called high mobility group A1 (HMGA1) may be the key that opens the door to the development of colon cancer, according ...
A look back at the Office of Technology Assessment, the Congressional think tank that detected lies and tested tech.
Evo 2 now includes information from humans, plants, and other eukaryotic species to expand its capabilities in generative functional genomics.
The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.
California-based nonprofit Arc Institute and Stanford University, in collaboration with NVIDIA, unveiled Evo 2 on Wednesday ...
Addressing the harmful chemical processes that accompany blunt force trauma to the brain can reduce the risk of long-term ...
NVIDIA BioNeMo can be used in biomolecular research applications such as predicting the form and function of proteins with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback